share_log

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

Benzinga ·  Oct 18 11:35  · Ratings

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment